Haiwen Liu

Dr. Haiwen Liu


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2015 in Viruses
Verified
Journal Article
Open access
PDF file
XYXiaoxue Yu
Xiaoxue Yu
LRLei Rui
Lei Rui
QSQiang Shao
Qiang Shao
HLHaiwen Liu
Haiwen Liu
YLYanan Lu
Yanan Lu
HLHaitao Li
Haitao Li
In the current study, we investigate changes in CD4+CD25+ cells in chickens during infectious bursal disease virus (IBDV) infection. The percentage of CD4+CD25+ cells in lymph organs, e.g., the thymus, spleen, bursa of Fabricius and peripheral blood, during the first 1–5 days post infection (dpi) was assessed by flow cytometry. The data revealed a remarkable decrease in the percentage of CD4+CD25+ cells in the thymus from 1 to 5 dpi and in the spleen during early infection. An increase of the percentage of CD4+CD25+ cells among peripheral blood lymphocytes was observed during the first two days of IBDV infection. Additionally, CD4+CD25+ cells infiltrated the bursa along with CD4+ cells after IBDV infection. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to measure the mRNA levels of immune-related cytokines in IBDV-infected thymus and bursa of Fabricius tissues. The data revealed that IBDV caused a significant increase in interleukin (IL)-10 mRNA levels, with the Harbin-1 strain (vvIBDV) inducing higher IL-10 expression than the Ts strain. Taken together, our data suggest that chicken CD4+CD25+ cells may participate in IBDV pathogenicity by migrating from their sites of origin and storage, the thymus and spleen, to the virally targeted bursa of Fabricius during IBDV infection.

13 July 2011 in Animal Science Journal
Verified
Journal Article
Closed access
PDF file
JGJunshuang Gao
Junshuang Gao
FYFang Yuan
Fang Yuan
XTXiaoyan Tang
Xiaoyan Tang
HHHaitang Han
Haitang Han
JSJin Sha
Jin Sha
HLHaitao Li
Haitao Li

3 September 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JTJingyu Tan
Jingyu Tan
XDXinlin Dong
Xinlin Dong
HLHaiwen Liu
Haiwen Liu
Cellular oxidative stress mediated by intrinsic and/or extrinsic reactive oxygen species (ROS) is associated with disease pathogenesis. Oxidative DNA damage can naturally be substituted by mitochondrial DNA (mtDNA), leading to base lesion/strand break formation, copy number changes, and mutations. In this study, we devised a single test for the sensitive quantification of acute mtDNA damage, repair, and copy number changes using supercoiling-sensitive quantitative PCR (ss-qPCR) and examined how oxidative stress-related mtDNA damage responses occur in oral cancer cells. We observed that exogenous hydrogen peroxide (H2O2) induced dynamic mtDNA damage responses, as reflected by early structural DNA damage, followed by DNA repair if damage did not exceed a particular threshold. However, high oxidative stress levels induced persistent mtDNA damage and caused a 5–30-fold depletion in mtDNA copy numbers over late responses. This dramatic depletion was associated with significant growth arrest and apoptosis, suggesting persistent functional consequences. Moreover, oral cancer cells responded differentially to oxidative injury when compared with normal cells, and different ROS species triggered different biological consequences under stress conditions. In conclusion, we developed a new method for the sensitive detection of mtDNA damage and copy number changes, with exogenous H2O2 inducing dynamic mtDNA damage responses associated with functional changes in stressed cancer cells. Finally, our method can help characterize oxidative DNA damage in cancer and other human diseases.

19 June 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JTJingyu Tan
Jingyu Tan
YLYan Liu
Yan Liu
BWBinbin Wang
Binbin Wang
HLHaiwen Liu
Haiwen Liu
Background: Neoadjuvant chemoimmunotherapy improves pathological response in resectable non-small cell lung cancer (NSCLC), but response remains heterogeneous. PD-L1 tumor proportion score (TPS) incompletely captures spatial immune contexture. We developed and cross-center validated an immunohistochemistry (IHC)-derived equal-weight immune niche score integrating tertiary lymphoid structure (TLS) maturity, CD8–TLS proximity, CD8/FOXP3 balance, CD163/CD68 ratio, and PD-L1 TPS. Methods: This two-center retrospective cohort included 326 patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy. The model-development cohort included 188 patients, and an institution-level external-validation cohort within the same regional medical system included 138 patients. The primary endpoint was major pathological response (MPR). Model performance was evaluated using discrimination, calibration, decision curve analysis, and ablation analysis. Sensitivity analyses tested alternative CD8–TLS thresholds, ICI-agent subgroups, missing-data approaches, Granzyme B incorporation, and alternative weighting. Exploratory analyses assessed event-free survival (EFS), overall survival (OS), interobserver reproducibility, and asthma-related pulmonary safety. Results: Overall, 146 patients (44.8%) achieved MPR and 42 (12.9%) achieved pathological complete response. MPR tumors had higher TLS maturity, CD8+ cells within 50 μm of TLS, CD8/FOXP3 ratio, PD-L1 TPS, lower CD163/CD68 ratio, and higher immune niche score. In external validation, the score achieved an AUC of 0.732 (95% CI, 0.648–0.816), compared with 0.564 for the clinical model, 0.635 for PD-L1 alone, 0.613 for clinical + PD-L1, and 0.692 for XGBoost, with acceptable calibration. CD8–TLS proximity (OR 1.68, 95% CI 1.03–2.79), CD163/CD68 ratio (OR 0.66, 95% CI 0.48–0.91), and the composite score (OR 2.72 per 1 SD, 95% CI 2.05–3.69) were independently associated with MPR. Performance was stable across sensitivity analyses. Exploratory EFS was more favorable in the high-score group. Asthma history was not independently associated with MPR but was associated with higher composite pulmonary adverse-event rates. Conclusion: This transparent IHC-derived TLS–CD8–macrophage immune niche score showed moderate cross-center validation performance for MPR prediction after neoadjuvant chemoimmunotherapy in resectable NSCLC, while remaining pathologically interpretable. It may complement PD-L1 TPS for response stratification, pending broader multicenter and prospective validation.

27 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JTJingyu Tan
Jingyu Tan
XDXinlin Dong
Xinlin Dong
HLHaiwen Liu
Haiwen Liu
Cellular oxidative stress mediated by intrinsic and/or extrinsic reactive oxygen species (ROS) is associated with disease pathogenesis. Oxidative DNA damage can naturally be substituted by mitochondrial DNA (mtDNA), leading to base lesion/strand break formation, copy number changes, and mutations. In this study, we devised a single test for the sensitive quantification of acute mtDNA damage, repair, and copy number changes using supercoiling-sensitive quantitative PCR (ss-qPCR) and examined how oxidative stress-related mtDNA damage responses occur in oral cancer cells. We observed that exogenous hydrogen peroxide (H 2 O 2 ) induced dynamic mtDNA damage responses, as reflected by early structural DNA damage, followed by DNA repair if damage did not exceed a particular threshold. However, high oxidative stress levels induced persistent mtDNA damage and caused a 5–30-fold depletion in mtDNA copy numbers over late responses. This dramatic depletion was associated with significant growth arrest and apoptosis, suggesting persistent functional consequences. Moreover, oral cancer cells responded differentially to oxidative injury when compared with normal cells, and different ROS species triggered different biological consequences under stress conditions. In conclusion, we developed a new method for the sensitive detection of mtDNA damage and copy number changes, with exogenous H 2 O 2 inducing dynamic mtDNA damage responses associated with functional changes in stressed cancer cells. Finally, our method can help characterize oxidative DNA damage in cancer and other human diseases.

11 December 2025 in Research Square
Verified
Preprint
Open access
PDF file
JTJingyu Tan
Jingyu Tan
YZYunping Zhang
Yunping Zhang
YGYuzhong Gao
Yuzhong Gao
YLYan Liu
Yan Liu
RFRongxin Fan
Rongxin Fan
HLHaiwen Liu
Haiwen Liu
Aim: This study aimed to explore a novel method for detecting the prostate cancer-specific fusion marker TMPRSS2:ERG to evaluate cancer risk and aggressiveness at diagnosis. Methods: We used prostate cancer cells from the Vcap sample, positive for TMPRSS2:ERG, as the experimental model. Female urine samples, TMPRSS2:ERG fusion-negative LNCaP cell samples, and clinical samples A203 and A204 served as controls. We established optimal conditions using quantitative PCR and droplet digital PCR (ddPCR). Dilution experiments were conducted with female urine samples. A total of 27 clinical urine samples from prostate cancer patients were retrospectively tested using ddPCR, while a prospective ddPCR experiment was conducted with 21 pathological RNA samples. Results: Dilution experiments indicated that ddPCR had a specificity of 99.9% for detecting prostate cancer fusion markers, achieving a sensitivity level capable of detecting a single fusion-positive cell among 10,000-20,000 cells in urine sediment. In multiplex testing, fusion marker detection rates were 59.3% in urine samples and 19% in pathological samples, with 100% specificity. Eleven cases exhibited multiple fusion subtypes, correlating with heightened cancer risk. Our method identified three patients with the rare subtype III, not previously detected by qPCR. Conclusions: The ddPCR platform provides high specificity and sensitivity for detecting fusion markers in prostate cancer, facilitating early diagnosis and concurrent analysis of rare subtypes.